The supplied evidence records concern EGFR trafficking, LDOC1βclathrin adaptor interactions, EGFR fucosylation in antiviral immunity, EGFR gene copy number screening, and EGFR-TKI sensitivity in NSCLC (e.g., a 200-patient NSCLC cohort linking LDOC1 loss to cytoplasmic EGFR and poorer gefitinib outcomes ). None address optimistic bias in food risk perception, direct versus indirect risk experience, or consumer psychology. No quantitative data on risk-optimism effect sizes, sample populations, or measurement instruments for that topic exist in the records.
What is missing: at minimum, studies operationalizing optimistic bias (e.g., comparative perceived-risk ratings for self vs others) across direct (personal experience) versus indirect (media/secondhand) food hazard exposure, with cohort sizes and effect statistics. Please supply the relevant psychology/food-risk evidence records to run the critique.
Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.